Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/06/2010 → 31/05/2013 |
Collaborative partners
- King's College London (lead)
- Queen Mary University of London
Harnessing the tumour-derived cytokine, CSF-1 to support adoptive immunotherapy of ovarian cancer using MUC1-targeted T-cells
- Maher, John (Primary Investigator)
- Burchell, Joy (Co-Investigator)
- Hagemann, Thorsten (Co-Investigator)
- Mullen, Gregory (Co-Investigator)
- Wilkie, Scott (Co-Investigator)
- academic, affiliated (Co-Investigator)
Project: Research